2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Neoadjuvant Therapy: new trials by email Literature Review of Neoadjuvant Therapy trials Research Report on Neoadjuvant Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Oxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab - Stomach Neoplasms, Esophagogastric Junction Disorder | Phase 2 | Terminated | Fudan University | 6 | 2021-09-28 | 2025-06-18 |
| Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients LUM015, Lum Imaging System - Breast Cancer, Neoadjuvant Therapy | Phase 2 | Terminated | Lumicell, Inc. | 98 | 2020-09-01 | 2025-01-15 |
Adenocarcinoma (1) · Breast Neoplasms (1) · Stomach Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Breast Diseases (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Stomach Diseases (1)
Oxaliplatin (1) · sintilimab (1) · tegafur-gimeracil-oteracil (1)
Fudan University (1) · Lumicell, Inc. (1)
China (1) · United States (1)
Barbara Smith, MD, PhD (1) · Jorge Ferrer, PhD (1)
R01CA212138 (1)